SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037714
Filing Date
2020-08-06
Accepted
2020-08-06 16:05:42
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldx-10q_20200630.htm   iXBRL 10-Q 2202080
2 EX-31.1 aldx-ex311_9.htm EX-31.1 17222
3 EX-31.2 aldx-ex312_8.htm EX-31.2 17442
4 EX-32.1 aldx-ex321_6.htm EX-32.1 9004
  Complete submission text file 0001564590-20-037714.txt   6789998

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aldx-20200630.xsd EX-101.SCH 43181
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20200630_cal.xml EX-101.CAL 43782
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20200630_def.xml EX-101.DEF 132672
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20200630_lab.xml EX-101.LAB 341292
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20200630_pre.xml EX-101.PRE 254768
10 EXTRACTED XBRL INSTANCE DOCUMENT aldx-10q_20200630_htm.xml XML 1168174
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 201081551
SIC: 2834 Pharmaceutical Preparations